Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningococcal Meningitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT07505888
What this trial is testing

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years

Who this might be right for
Epidemic MeningitisMeningococcal Vaccines
Sinovac Biotech Co., Ltd 660
Post-approval studies (Phase 4)Study completedNCT01823536
What this trial is testing

Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster Dose

Who this might be right for
Meningococcal Disease
Novartis Vaccines 465
Large-scale testing (Phase 3)Study completedNCT00450437
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults

Who this might be right for
Meningococcal InfectionsMeningococcal Meningitis
Novartis Vaccines 3,539
Large-scale testing (Phase 3)Study completedNCT00539032
What this trial is testing

Immunology and Safety of Menactra® in Children in Saudi Arabia

Who this might be right for
MeningitisMeningococcemia
Sanofi Pasteur, a Sanofi Company 238
Large-scale testing (Phase 3)Study completedNCT03077438
What this trial is testing

Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 1,000
Large-scale testing (Phase 3)Study completedNCT02173704
What this trial is testing

Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan.

Who this might be right for
Meningococcal DiseaseInfections, Meningococcal
GlaxoSmithKline 225
Post-approval studies (Phase 4)Study completedNCT00310700
What this trial is testing

Kinetics of B Cell Response in Infants Menjugate Vaccination

Who this might be right for
Prevention of Meningococcal Infection
Novartis 75
Testing effectiveness (Phase 2)UnknownNCT06337071
What this trial is testing

The ACYW135 Meningococcal Polysaccharide Conjugate Vaccine

Who this might be right for
Meningococcal Meningitis
Aimei Vacin BioPharm (Zhejiang) Co., Ltd. 1,200
Large-scale testing (Phase 3)Study completedNCT00474526
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants

Who this might be right for
Meningitis, Meningococcal
Novartis Vaccines 4,545
Testing effectiveness (Phase 2)Study completedNCT03433482
What this trial is testing

Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 1,707
Testing effectiveness (Phase 2)Study completedNCT00459316
What this trial is testing

Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth

Who this might be right for
HIV InfectionsMeningitis
National Institute of Allergy and Infectious Diseases (NIAID) 384
Large-scale testing (Phase 3)Looking for participantsNCT07505836
What this trial is testing

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months

Who this might be right for
Epidemic MeningitisMeningococcal Vaccines
Sinovac Biotech Co., Ltd 1,040
Testing effectiveness (Phase 2)Study completedNCT00297817
What this trial is testing

Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adolescents

Who this might be right for
Meningococcal Disease
Novartis Vaccines 203
Testing effectiveness (Phase 2)Study completedNCT00772070
What this trial is testing

Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine

Who this might be right for
MeningitisMeningococcemiaNeisseria Meningitidis
Sanofi Pasteur, a Sanofi Company 173
Large-scale testing (Phase 3)Study completedNCT01725217
What this trial is testing

Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Children, Adolescents and Adults in Russia

Who this might be right for
Meningococcal Disease
Novartis Vaccines 198
Early research (Phase 1)Study completedNCT01889836
What this trial is testing

Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos

Who this might be right for
Meningitis, Meningococcal, Serogroup C
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 60
Large-scale testing (Phase 3)Study completedNCT01423084
What this trial is testing

Safety and Immunogenicity of Novartis Meningococcal B Vaccine Formulated With OMV Manufactured at Two Different Sites, in Healthy Adolescents Aged 11-17 Years

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis 344
Testing effectiveness (Phase 2)Study completedNCT01461993
What this trial is testing

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Who this might be right for
VaccinesMeningococcal Vaccines
Pfizer 2,499
Large-scale testing (Phase 3)Study completedNCT00161928
What this trial is testing

Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants

Who this might be right for
Meningitis, Meningococcal
Pfizer 330
Testing effectiveness (Phase 2)Study completedNCT01732627
What this trial is testing

Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections+1 more
Sanofi Pasteur, a Sanofi Company 301
Next Page